BioCryst Pharmaceuticals Ownership | Who Owns BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals Ownership Summary
BioCryst Pharmaceuticals is owned by 83.36% institutional investors, 1.15% insiders, and 15.49% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 10.68% of BCRX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.20% of its assets in BioCryst Pharmaceuticals shares.
BCRX Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | BioCryst Pharmaceuticals | 83.36% | 1.15% | 15.49% |
Sector | Healthcare Stocks | 279.19% | 10.58% | -189.76% |
Industry | Biotech Stocks | 63.97% | 10.68% | 25.35% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock funding, inc. /de | 22.10M | 10.68% | $166.16M |
Vanguard group | 21.89M | 10.58% | $164.62M |
Blackrock | 19.96M | 9.68% | $123.33M |
Avoro capital advisors | 11.87M | 5.73% | $89.22M |
Kynam capital management, lp | 9.09M | 4.39% | $68.32M |
Deerfield management company, l.p. (series c) | 8.14M | 3.94% | $61.25M |
State street | 7.50M | 3.62% | $56.39M |
Alkeon capital management | 7.09M | 3.43% | $53.35M |
Geode capital management | 4.82M | 2.33% | $36.28M |
Rp management | 3.85M | 1.86% | $29.23M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Rp management | 3.85M | 12.84% | $29.23M |
Caligan partners lp | 3.00M | 5.71% | $22.53M |
Kynam capital management, lp | 9.09M | 4.04% | $68.32M |
Eversept partners, lp | 1.98M | 1.32% | $14.89M |
Dafna capital management | 667.00K | 1.27% | $5.02M |
Avoro capital advisors | 11.87M | 1.26% | $89.22M |
Knott david m jr | 440.00K | 1.20% | $3.31M |
Deerfield management company, l.p. (series c) | 8.14M | 1.16% | $61.25M |
Rice hall james & associates | 2.08M | 0.86% | $15.65M |
Semanteon capital management, lp | 197.76K | 0.80% | $1.49M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Vanguard group | 21.89M | 0.00% | 1.58M |
Blackrock | 19.96M | 0.00% | 1.52M |
Eversept partners, lp | 1.98M | 1.32% | 1.44M |
Blackrock funding, inc. /de | 22.10M | 0.00% | 1.18M |
Cubist systematic strategies | 1.11M | 0.05% | 935.13K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Braidwell lp | - | - | -3.38M |
Price t rowe associates inc /md/ | 126.81K | 0.00% | -2.13M |
Point72 asset management | - | - | -1.62M |
Nuveen asset management | 3.42M | 0.01% | -1.40M |
State street | 7.50M | 0.00% | -1.35M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Balyasny asset management | 529.65K | 0.01% | 529.65K | $3.98M |
Norges bank | 524.80K | 0.00% | 524.80K | $3.95M |
Graham capital management | 97.26K | 0.01% | 97.26K | $731.37K |
Susquehanna fundamental investments | 88.85K | 0.01% | 88.85K | $668.18K |
Ieq capital | 29.44K | 0.00% | 29.44K | $221.36K |
Sold Out
Holder | Change |
---|---|
Tfo-tdc | -3.00 |
Financial gravity asset management | -8.00 |
Dinuzzo private wealth | -13.00 |
Newbridge financial services group | -15.00 |
Sjs investment consulting | -20.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 277 | 2.59% | 174,118,175 | 3.86% | 83 | 1.27% | 150 | 29.31% | 66 | -25.00% |
Dec 31, 2024 | 265 | -1.49% | 167,630,080 | -2.81% | 81 | 1.17% | 114 | -14.29% | 87 | 17.57% |
Sep 30, 2024 | 268 | 7.63% | 172,429,027 | -1.07% | 83 | 1.17% | 134 | 5.51% | 73 | 8.96% |
Jun 30, 2024 | 246 | -1.99% | 174,231,087 | -2.64% | 84 | 1.12% | 125 | 7.76% | 67 | -4.29% |
Mar 31, 2024 | 251 | 1.62% | 178,960,740 | 1.28% | 86 | 1.03% | 116 | 3.57% | 70 | -10.26% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 6.69M | 3.20% | 138.35K |
Vanguard US Total Market Shares ETF | 6.57M | 3.14% | -18.55K |
iShares Russell 2000 ETF | 5.28M | 2.52% | 2.59K |
ACAP Strategic A | 3.46M | 1.66% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 3.23M | 1.54% | 4.29K |
SPDR® S&P Biotech ETF | 2.86M | 1.37% | 3.70K |
Vanguard Small Cap Index | 2.63M | 1.25% | 21.09K |
Fidelity Small Cap Index | 2.05M | 0.98% | 13.48K |
Vanguard Strategic Equity Inv | 1.94M | 0.93% | 100.59K |
iShares Russell 2000 Growth ETF | 1.79M | 0.86% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Dec 13, 2024 | Hutson Nancy J | - | Sell | $52.78K |
Jun 24, 2024 | McKee Amy E | - | Sell | $54.35K |
Jun 17, 2024 | SANDERS MACHELLE | - | Sell | $28.13K |
Jun 14, 2024 | HEGGIE THERESA | - | Sell | $40.92K |
May 30, 2024 | LEVIN ALAN G | - | Buy | $50.00K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | - |
2024 Q4 | - | 1 |
2024 Q3 | - | - |
2024 Q2 | 10 | 3 |
2024 Q1 | - | - |
BCRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools